P
Pi Health
Pi Health pioneers health tech and clinical research, revolutionizing global access to cutting-edge medicines and clinical trials
About Pi Health
Pi Health operates as an oncology-focused health technology and clinical research organization, established in 2021 by co-founders Dr. Geoffrey Kim and Dr. Bobby Reddy. The company was initially incubated as a subsidiary of the global biotechnology company BeiGene before launching independently. In March 2024, Pi Health secured over $30 million in a Series A funding round led by AlleyCorp and Obvious Ventures, with participation from Invus Capital. This financing is intended to support the expansion of its global trial site partnerships and the further development of its core technology.
The founders bring extensive experience in oncology and regulatory affairs to the company. Dr. Geoffrey Kim, the CEO, has over 25 years of experience in oncology drug development and previously served as the Deputy Director of the Oncology Center of Excellence at the U.S. Food and Drug Administration (FDA), in addition to holding leadership roles at AstraZeneca and BeiGene. Dr. Bobby Reddy, the COO, also held leadership positions at BeiGene and AstraZeneca and is a practicing dermatologist at Massachusetts General Hospital. Their collective background in cancer treatment and clinical trial regulation directly informs the company's mission to address inefficiencies in the drug development process.
The company's business is centered on improving the clinical trial process for life sciences companies, specifically within oncology. Pi Health addresses the challenge of low patient participation in clinical studies, where fewer than 8% of eligible cancer patients enroll, by connecting pharmaceutical companies and trial sponsors with a diverse, global patient population. This is achieved through its proprietary software platform, FICS (Front-End Interoperable Capture Software), and a growing international network of clinical trial sites across the US, Brazil, Australia, and India. Revenue is generated by providing this integrated solution to life sciences companies to help them develop medicines faster and more cost-effectively.
The FICS platform is a comprehensive, AI-powered system designed to replace multiple, disconnected software solutions often used in clinical trials. It unifies capabilities for electronic data capture (EDC), clinical trial management (CTMS), and trial master file (TMF) management into a single interface. Key features include the automation of manual processes for data collection, the generation of regulatory-grade data from the outset, and tools to streamline communication between trial sites and sponsors. By using generative AI, the platform also assists with automating clinical documentation and matching patients to appropriate trials. A significant milestone was the opening of the Pi Health Cancer Hospital in Hyderabad, India, in 2023, which serves as a model site showcasing the platform's ability to manage clinical trial data and operations efficiently.
Source: Dealroom company dataNews
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | Apr 2026 | $0 | — | Pi Holdings Corp | ↗ |
| SERIES A✓Equity / VC | Mar 2024 | $30M | $120M | Obvious Ventures · AlleyCorp · Invus | ↗ |
Growth signals
Latest recorded traffic for Pi Health is 3.5K monthly website visits, up 169.2% over the last three months. Pi Health's team declined 4.4% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
| Company | Headquarters | Status | Employees | Total funding | Valuation |
|---|---|---|---|---|---|
Boston Health AIAI-driven physician assistant transforming healthcare with efficient SOAP notes and personalized treatment options |
— | Operational | 70 | — | — |
MyRxWallet CorporationHealth Tech & Medtech |
Las Vegas, United States | Operational | |||
NucleusaiAutomatizing technology solutions with AI methods and computing advances |
— | Operational | |||
Neu HealthSmartphone platform for Parkinson's and dementia care |
London, United Kingdom | Operational | |||
EmocionalAI based SaaS solution for real-time video-conference emotional well-being analysis of hybrid and remote teams |
Barcelona, Spain | Operational | |||
Quahog LifeArtificially intelligent patient company |
Bengaluru, India | Operational | |||
PicturaBioBuilding instant pathogen tests using super-resolution microscopy and machine learning |
Oxford, United Kingdom | Operational | |||
Yuko AITo enable a world with equitable access to healthcare |
Toronto, Canada | Operational |
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Pi Health in the Cambridge ecosystem
The Pi Health office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
Obvious Ventures
AlleyCorp
Invus
Other known investors1 additional known investor
- PCPi Holdings Corp
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Pi Health on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Pi Health’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








